Back

New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness

29 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Risk stratification of cardiomyopathies with echocardiography Tissue Doppler, Speckle Tracking and Strain Imaging ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Isabel Mattig

German Heart Centre Berlin, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Could echocardiographic left atrial characterization have additive value for detecting risks of atrial arrhythmias and stroke in patients with hypertrophic cardiomyopathy?
Mr A. Al wazzan (Rennes, FR)
Abstract Slides
Presentation thumbnail
A novel echocardiographic risk score predicts prognosis in AL-amyloidosis
Doctor P. Geenty (Westmead, AU)
Abstract Slides
Presentation thumbnail
Echocardiographic assessment of left ventricular radial strain to differentiate cardiac amyloidosis from Fabry disease
Mr T. Steudel (Berlin, DE)
Abstract Slides
Presentation thumbnail
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy
Doctor A. Amador (Porto, PT)
Abstract Slides
Presentation thumbnail
Quantification of systolic anterior motion of the mitral valve to predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
Doctor D. Zach (Salzburg, AT)
Abstract Slides

Access the full session

Session thumbnail
Risk stratification of cardiomyopathies with echocardiography

The Event

Event poster

ESC Congress 2022

29 August 2022 08:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources